Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK

By Wade Alan G.   Saragoussi Delphine   Despiégel Nicolas   François Clément   Guelfucci Florent   Toumi Mondher  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases

By Wang Junling   Liu Xianchen   Mullins C. Daniel  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1303-1313

Informa Healthcare

Access to resources Recommend Favorite

Venlafaxine, but Not Mirtazapine Lowers Retinol-Binding Protein 4 Serum Concentrations in Nondiabetic Depressed Patients

By  

Psychotherapy and Psychosomatics, Vol. 79, Iss. 2, 2009-02 ,pp. : 123-125

Karger

Access to resources Recommend Favorite

Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder

By van Baardewijk M.   Vis P. M. J.   Einarson T. R.  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR

By Eckert Laurent   Falissard Bruno  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2313-2321

Informa Healthcare

Access to resources Recommend Favorite